Sulfated carboxymethylcellulose-based scaffold mediated delivery of Timp3 alleviates osteoarthritis

Int J Biol Macromol. 2022 May 16:S0141-8130(22)01063-7. doi: 10.1016/j.ijbiomac.2022.05.093. Online ahead of print.ABSTRACTOsteoarthritis (OA) is a debilitating progressive joint disease with high incidence and socioeconomic burden. However, no disease-modifying treatment is currently available for OA. Here, we report a sulfated carboxymethylcellulose-based scaffold mediated delivery of tissue inhibitor of metalloprotease 3 (Timp3) as a disease-modifying therapeutic strategy for OA. First, we chemically modified carboxymethylcellulose (CMC) to sulfated carboxymethylcellulose (sCMC) to impart native-like electrostatic interaction-based binding of cationic proteins. We then fabricated cartilage ECM mimicking sCMC-gelatin scaffolds which showed preferential binding and sustained delivery of Timp3. This scaffold-mediated delivery of Timp3 demonstrated a reduction in matrix degradation, protease expression and inflammatory markers in the goat ex vivo OA model leading to enhanced retention of cartilage ECM markers when compared to OA control. Further, similar results were obtained when sCMC-gelatin scaffolds were evaluated using human OA samples, supporting its clinical potential. Overall, the Timp3 loaded sCMC-gelatin scaffold shows potential as a treatment approach for OA.PMID:35588980 | DOI:10.1016/j.ijbiomac.2022.05.093
Source: International Journal of Biological Macromolecules - Category: Biochemistry Authors: Source Type: research